Ester Carreón Guarnizo

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

José Ignacio Fernández-Velasco, Jens Kühle, Enric Monreal et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 61 citations · Full text

Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis

Naresh Mutukula, Zhiqiu Man, Yuta Takahashi et al. · Stem Cell Research · 2021 · 22 citations · Full text

Possible Influence of the Route of Treatment Administration on Treatment Adherence in Patients With Multiple Sclerosis

I Sánchez-Martínez, María Cerdán Sánchez, Javier López Román et al. · Clinical Therapeutics · 2020 · 18 citations

Patient Support, Treatment Option, Rehabilitation +4

Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders

Ester Carreón Guarnizo, R. Hernández Clares, Tamara Castillo‐Triviño et al. · Neurología (English Edition) · 2021 · 18 citations · Full text

Prevention of rebound effect after natalizumab withdrawal in multiple sclerosis. Study of two high-dose methylprednisolone schedules

Luna Fuentes-Rumí, R. Hernández-Clares, Ester Carreón Guarnizo et al. · Multiple Sclerosis and Related Disorders · 2020 · 11 citations

Medicine, Rebound Effect, Pharmacology +7